Benlysta subcutaneous injection 200mg autoinjector, manufactured by GlaxoSmithKline, contains Belimumab (genetical recombination) (YJ code: 3999445G2023, 200mg 1mL 1 kit). It is a BLyS-specific inhibitor used to treat active systemic lupus erythematosus (SLE) and active lupus nephritis in adults.
Benlysta subcutaneous injection 200mg autoinjector
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →